Millennial physicians ages 26 to 36 are bringing a new perspective to patient relationships, clinical decision making and attitudes regarding the pharmaceutical industry, according to a survey published by inVentiv Health.
Here are seven statistics from the survey that offer a glimpse into the world of the millennial physician.
- Two-thirds of millennial physicians tailor their approach to care delivery to the age of the patient. This means they may ask a fellow millennial patient to do more research on their own, and would provide simplified explanations for non-millennial patients.
- Roughly half (42 percent) of millennial physicians said they find peer education experiences are the best vehicle to learn about new treatments, compared to 18 percent of non-millennial physicians.
- Few millennial physicians (16 percent) find pharmaceutical manufacturers influence their decisions to use new treatments, compared to 48 percent of older physicians.
- Almost two-thirds of millennial physicians (60 percent) said they would be more likely to see a pharmaceutical sales representative if the rep has patient programs in his or her portfolio.
- Millennial physicians value discussion guides (48 percent) and adherence support (40 percent) most from pharmaceutical reps.
- Most millennial providers (81 percent) believe direct-to-consumer advertising becomes a burden for them because patients ask for medications they don't need.
- Millennial physicians are less likely than their older counterparts to be swayed by patient requests for medications and treatments, at 23 percent and 41 percent, respectively.
More articles on integration and physician issues:
Movie producers & Pulitzer Prize winners: Who is speaking at grad ceremonies for 10 top medicals schools
Viewpoint: It's about time for more urgent care options in Boston
How Louisiana is making its physician shortage worse